The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II
Abstract
The p170 and p180 forms of topoisomerase II have been compared. The concentration dependence of ATP for catalytic activity of the two forms of the enzyme was identical, and each was equally sensitive to novobiocin. Orthovanadate was found to be a potent inhibitor of catalytic activity of both p170 and p180, with an IC50 value of about 2 microM for each. Under standard reaction conditions, relaxation of supercoiled pBR322 by p180 was highly processive, while p170 performed the same reaction in a distributive manner. The optimal concentration of KCl for catalytic activity of p180 was 20-30 mM higher than that for p170. Comparison of their thermal stability showed that p180 was inactivated at twice the rate of p170. Teniposide and merbarone selectively inhibited catalytic activity of p170, requiring concentrations 3-fold and 8-fold lower, respectively, than those required for equivalent inhibition of p180. Similar selectivity for p170 was seen for teniposide-stimulated DNA cleavage or its inhibition by merbarone. Analysis of sites of DNA cleavage indicated a subset of sites that were either preferred or unique for each of the enzymes. A synthetic oligonucleotide representative of p170 sites selectively inhibited the p170 enzyme. Immunoblotting of p170 and p180 from U937 cells at different stages of proliferation showed that p170 levels declined as the cells reached the plateau phase of growth, while p180 levels were low during rapid proliferation and increased as the growth rate slowed. The data indicate that the p170 and p180 forms of topoisomerase II can be distinguished biochemically, pharmacologically, and by differential cellular regulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Matsudaira, P. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61070-1 · Cited by 4,950
Organization of the higher-order chromatin loop: specific DNA attachment sites on nuclear scaffold
Mirkovitch, J., Mirault, M.-E., & Laemmli, U. K. (1984) · Cell · doi:10.1016/0092-8674(84)90208-3 · Cited by 1,066
Topoisomerase II is a structural component of mitotic chromosome scaffolds.
Earnshaw, W. C., Halligan, B., Cooke, C. A., Heck, M. M., & Liu, L. F. (1985) · The Journal of cell biology · doi:10.1083/jcb.100.5.1706 · Cited by 749
DNA topoisomerase II is required at the time of mitosis in yeast
HOLM, C., GOTO, T., WANG, J., & BOTSTEIN, D. (1985) · Cell · doi:10.1016/s0092-8674(85)80028-3 · Cited by 742
Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate
Swarup, G., Cohen, S., & Garbers, D. L. (1982) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(82)90635-0 · Cited by 685
DiNardo, S., Voelkel, K., & Sternglanz, R. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.9.2616 · Cited by 674
Metaphase chromosome structure
Gasser, S. M., Laroche, T., Falquet, J., Boy de la Tour, E., & Laemmli, U. K. (1986) · Journal of Molecular Biology · doi:10.1016/s0022-2836(86)80010-9 · Cited by 536
Cleavage of DNA by mammalian DNA topoisomerase II.
Liu, L. F., Rowe, T. C., Yang, L., Tewey, K. M., & Chen, G. L. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43815-4 · Cited by 533
Localization of topoisomerase II in mitotic chromosomes.
Earnshaw, W. C., & Heck, M. M. (1985) · The Journal of cell biology · doi:10.1083/jcb.100.5.1716 · Cited by 495
Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage.
Ross, W. E., Rowe, T., Glisson, B. S., Yalowich, J. C., & Liu, L. F. (1984) · PubMed · Cited by 459
Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle.
Heck, M. M., Hittelman, W. N., & Earnshaw, W. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.4.1086 · Cited by 409
DNA Topoisomerases: Enzymes That Control DNA Conformation
Vosberg, H.-P. (1985) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-70227-3_2 · Cited by 321
The organisation of chromatin loops: characterization of a scaffold attachment site
Gasser, S. M., & Laemmli, U. K. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04240.x · Cited by 302
Drake, F., Zimmerman, J., McCabe, F., Bartus, H., Per, Sr., Sullivan, D., Ross, W., Mattern, M., Johnson, R., & Crooke, S. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)49317-9 · Cited by 277
Self-citationMechanistic Aspects of DNA Topoisomerases
Maxwell, A., & Gellert, M. (1986) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60526-4 · Cited by 258
Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells.
Hsiang, Y. H., Wu, H. Y., & Liu, L. F. (1988) · PubMed · Cited by 247
Novel topologically knotted DNA from bacteriophage P4 capsids: studies with DNA topoisomerases
Liu, L. F., Davis, J. L., & Calendar, R. (1981) · Nucleic Acids Research · doi:10.1093/nar/9.16.3979 · Cited by 220
Eukaryotic topoisomerase II. Characterization of enzyme turnover.
Osheroff, N. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67607-0 · Cited by 206
Illegitimate recombination mediated by calf thymus DNA topoisomerase II in vitro.
Bae, Y. S., Kawasaki, I., Ikeda, H., & Liu, L. F. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.7.2076 · Cited by 165
Sullivan, D. M., Latham, M. D., & Ross, W. E. (1987) · PubMed · Cited by 145
Glisson, B. S., & Ross, W. E. (1987) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(87)90054-4 · Cited by 144
Topoisomerase-specific drug sensitivity in relation to cell cycle progression.
Chow, K., & Ross, W. E. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.9.3119 · Cited by 141
Lynn, R., Giaever, G. N., Swanberg, S. L., & Wang, J. C. (1986) · Science · doi:10.1126/science.3014661 · Cited by 126
Willems, M., Wagner, E. K., Laing, R., & Penman, S. (1968) · Journal of Molecular Biology · doi:10.1016/0022-2836(68)90005-3 · Cited by 115
Hirose, S., & Suzuki, Y. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.3.718 · Cited by 73
Pommier, Y. G., Kerrigan, D., Covey, J. M., Kao-Shan, C. S., & Whang‐Peng, J. (1988) · PubMed · Cited by 71
Gyration is required for 5S RNA transcription from a chromatin template.
Kmiec, E. B., Ryoji, M., & Worcel, A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.5.1305 · Cited by 48
Cited by
Overview of resistance to systemic therapy in patients with breast cancer
Gonzalez-Angulo, A. M., Morales-Vasquez, F., & Hortobagyi, G. N. (2007) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-74039-3_1 · Cited by 904
Topoisomerase Poisons: Harnessing the Dark Side of Enzyme Mechanism
Froelich-Ammon, S. J., & Osheroff, N. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.21429 · Cited by 505
Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme
Burden, D. A., & Osheroff, N. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00132-8 · Cited by 503
DNA topoisomerases: harnessing and constraining energy to govern chromosome topology
Schoeffler, A. J., & Berger, J. M. (2008) · Quarterly Reviews of Biophysics · doi:10.1017/s003358350800468x · Cited by 490
The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing
Deweese, J. E., & Osheroff, N. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn937 · Cited by 462
Metadata
- Authors
- Drake, F. H., Hofmann, G. A., Bartus, H. F., Mattern, M. R., Crooke, S. T., & Mirabelli, C. K.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1989-10-01
- Volume
- 28
- Issue
- 20
- Pages
- 8154-8160
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W1979936660
- Cited by
- 410
- References
- 28
- FWCI
- 5.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.